Expression of a specific subset of CD44 variant transcripts in NOD pancreatic islets

Diabetes

Volumn 45, Issue 6, 1996, Pages 718-724

  Milde, Kerstin F ^a   Alonso, Miriam ^a   Kong, Shen Shen ^a   Alejandro, Rodolfo ^a   Mintz, Daniel H ^a   Pastori, Ricardo L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA PROBE; EXON; FEMALE; GENE EXPRESSION; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN CELL;

EID: 0029889759     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.718     Document Type: Article

References (39)

1. Castano L, Eisenbarth GS: Type I diabetes: a chronic autoimmune disease of man, mouse and ral. Annu Rev Immunol 8:647-649, 1990
2. Rossini AA, Greiner DL, Friedman, HP, Mordes JP: Immunopathogenesis of diabetes mellitus. Diabetes Rev 1:43-75, 1993
3. Trucco M, Dorman JS: Immunogenetics of insulin-dependent diabetes mellitus in humans. Crit Rev Immunol 9:201-245, 1989
4. Makino S, Kunimoto K, Muraoka Y, Mizuishima, Y, Katagiri K, Tochino Y: Breeding of a non-obese diabolic strain of mice. Exp Anim 29:1-13, 1980
5. Fujita T, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y: Lymphocytic insulitis in a nonobese diabetic (NOD) strain of mice: an immunohistochemical and electron microscope investigation. Biomed Res 3:429-443, 1982
6. Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 165:1639-1654, 1987
7. Serreze DV, Leiter HE: Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol 7:900-906, 1992
8. Woodruff JJ, Clarke LM, Chin YH: Specific cell-adhesion mechanisms determining migration pathways of recirculating lymphocytes. Annu Rev Immunol 5:202-222, 1987
9. Faveeuw C, Gagnerault MC, Lepault F: Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J Immunol 152:5969-5978, 1994
10. Hanninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, Shizuru JA, Simell O, Michie SA: Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 95:2509-2515, 1993
11. Yang XD, Karin N, Tisch R, Steinman L, McDevitt HO: Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci USA 90:10494-10498, 1993
12. Yang XD, Michie SA, Tisch R, Karin N, Steinman L, McDevitt HO: A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 91:12604-12608, 1994
13. Lesley J, Hyman R, Kincade PW: CD44 and its interactions with extracellular matrix. Adv Immunol 54:271-335, 1993
14. Bourguignon LYW, Kalomiris EL, Lokeshwar VB: Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J Biol Chem 266:11761-11765, 1991
15. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825, 1992
16. Jalkanen S, Bargatze J, de los Toyos RF, Butcher EC: Lymphocyte recognition in high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol 105:983-990, 1987
17. Haynes B, Telen MJ, Hale LP, Denning SM: CD44 a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423-428, 1989
18. Screaton GR, Bell M, Jackson DG, Cornelis FB, Gorth U: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternative spliced exons. Proc Natl Acad Sci USA 89:12160-12161, 1992
19. Tölg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225-1229, 1993
20. Ricordi C, Tzakis AG, Carroll PB, Zeng Y, Rilo HLR, Alejandro R, Shapiro R, Fung JJ, Demetris AJ, Mintz DH, Starzl T: Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 53:407-414, 1992
21. Milde KF, Alejandro R, Pastori RL: Expression of CD44 variant transcripts in dog lymphatic tissue. Immunogenetics 40:437-444, 1994
22. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136-4150, 1993
23. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli JD, Vassalli P: Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1731, 1992
24. Christianson SW, Shultz LD, Leiter EH: Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Diabetes 42:44-55, 1993
25. Huang X, Hultreg B, Dybdal N, Stewart TA: Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1:409-478, 1994
26. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, MacDevitt HO: Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995-1004, 1994
27. de Kossodo S, Grau GE, Daneva T, Pointaire P, Fossati L, Ody C, Zapf J, Piguet PF, Gaillard RC, Vassalli P: Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development. J Exp Med 176:1259-1264, 1992
28. Wogensen L, Huang X, Sarvetnick N: Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 178:175-185, 1993
29. Ihm S-H, Yoon JW: Macrophages essential for development of beta cell-specific cytotoxic effectors and insulitis in NOD mice. Diabetes 39:1273-1278, 1990
30. Mikecz K, Brennan FR, Kim JH, Giant TT: Anti-CD44 abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1:558-563, 1995
31. Rosenberg WMC, Prince C, Kaklamanis L, Fox SB, Jackson DG, Simmons DL, Chapman RW, Trowell JM, Jewell DP, Bell JI: Increased expression of CD44 v6 and CD44 v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345:1205-1209, 1995
32. Gunthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24, 1991
33. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292-5297, 1991
34. Herrlich P, Zöller M, Pals ST, Ponta H: CD44 splice variants: metastases meet lymphocytes. Immunol Today 14:395-399, 1993
35. Hirano H, Screaton GR, Bell M, Jackson DG, Bell J, Hodes RJ: CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol 6:49-59, 1993
36. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J Biol Chem 268:12235-12238, 1993
37. Tanaka Y, Adams DH, Shaw S: Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14:111-115, 1993
38. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenokovic I, Plowman G, Arrufo A: CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687-698, 1995
39. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685, 1995